In this issue:
- Impact of autoantibodies on biological DMARD efficacy in RA
- Global axial SpA functioning associated more with disease activity/function than mobility/radiographic damage
- Preferences for tapering biologic DMARDs in RA
- PsA phenotype clusters and their associations with treatment response
- Relapse in stable SLE after glucocorticoid withdrawal
- Disease activity, remission and relapse in polymyalgia rheumatica
- Predicting overlap syndrome risk in SLE
- Early vs. late transition from psoriasis to PsA
- Short-term CV event risk in newly diagnosed gout
- CV events in gout on urate-lowering therapy initiation ± colchicine
Please login below to download this issue (PDF)